Search research articles
Contact Us
Filters
Showing results (241-250 of 308) with videos related to
Page
of 31
Sort By:
Annals of Neurology
|
June 3, 2021
Longitudinal CSF Iron Pathway Proteins in Posthemorrhagic Hydrocephalus: Associations with Ventricle Size and Neurodevelopmental Outcomes
Jennifer M Strahle, Kelly B Mahaney, Diego M Morales, et al.
Frontiers in Immunology
|
May 24, 2021
TIGIT and PD-1 Immune Checkpoint Pathways Are Associated With Patient Outcome and Anti-Tumor Immunity in Glioblastoma
Itay Raphael, Rajeev Kumar, Lauren H McCarl, et al.
Plos One
|
March 10, 2021
Cerebrospinal fluid NCAM-1 concentration is associated with neurodevelopmental outcome in post-hemorrhagic hydrocephalus of prematurity
David D Limbrick, Diego M Morales, Chevis N Shannon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 15, 2010
Induction of CD8+ T-cell responses against novel glioma-associated antigen peptides and clinical activity by vaccinations with {alpha}-type 1 polarized dendritic cells and polyinosinic-polycytidylic acid stabilized by lysine and carboxymethylcellulose in patients with recurrent malignant glioma
Hideho Okada, Pawel Kalinski, Ryo Ueda, et al.
Journal of Neurosurgery. Pediatrics
|
January 23, 2026
Clinical presentation of hydrocephalus following pre- and postnatal myelomeningocele repair: a Hydrocephalus Clinical Research Network study
Sasidhar Karuparti, Hailey Jensen, Ron W Reeder, et al.
Journal of Neurosurgery. Pediatrics
|
July 28, 2022
Hydrocephalus surveillance following CSF diversion: a modified Delphi study
David S Hersh, Jonathan E Martin, Ruth E Bristol, et al.
The Journal of Experimental Medicine
|
December 6, 2017
Novel and shared neoantigen derived from histone 3 variant H3.3K27M mutation for glioma T cell therapy
Zinal S Chheda, Gary Kohanbash, Kaori Okada, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 18, 2018
Extensive Molecular and Clinical Heterogeneity in Patients With Histologically Diagnosed CNS-PNET Treated as a Single Entity: A Report From the Children's Oncology Group Randomized ACNS0332 Trial
Eugene I Hwang, Marcel Kool, Peter C Burger, et al.
Brain Pathology (Zurich, Switzerland)
|
March 5, 2013
Histological predictors of outcome in ependymoma are dependent on anatomic site within the central nervous system
Aditya Raghunathan, Khalida Wani, Terri S Armstrong, et al.
Neuro-Oncology Advances
|
April 10, 2024
Vorinostat, temozolomide or bevacizumab with irradiation and maintenance BEV/TMZ in pediatric high-grade glioma: A Children's Oncology Group Study
Rishi R Lulla, Allen Buxton, Mark D Krailo, et al.
Page
of 31
Search research articles
Search
Showing results (241-250 of 308) with videos related to
Sort By:
Page
of 31
Annals of Neurology
|
June 3, 2021
Longitudinal CSF Iron Pathway Proteins in Posthemorrhagic Hydrocephalus: Associations with Ventricle Size and Neurodevelopmental Outcomes
Jennifer M Strahle, Kelly B Mahaney, Diego M Morales, et al.
Frontiers in Immunology
|
May 24, 2021
TIGIT and PD-1 Immune Checkpoint Pathways Are Associated With Patient Outcome and Anti-Tumor Immunity in Glioblastoma
Itay Raphael, Rajeev Kumar, Lauren H McCarl, et al.
Plos One
|
March 10, 2021
Cerebrospinal fluid NCAM-1 concentration is associated with neurodevelopmental outcome in post-hemorrhagic hydrocephalus of prematurity
David D Limbrick, Diego M Morales, Chevis N Shannon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 15, 2010
Induction of CD8+ T-cell responses against novel glioma-associated antigen peptides and clinical activity by vaccinations with {alpha}-type 1 polarized dendritic cells and polyinosinic-polycytidylic acid stabilized by lysine and carboxymethylcellulose in patients with recurrent malignant glioma
Hideho Okada, Pawel Kalinski, Ryo Ueda, et al.
Journal of Neurosurgery. Pediatrics
|
January 23, 2026
Clinical presentation of hydrocephalus following pre- and postnatal myelomeningocele repair: a Hydrocephalus Clinical Research Network study
Sasidhar Karuparti, Hailey Jensen, Ron W Reeder, et al.
Journal of Neurosurgery. Pediatrics
|
July 28, 2022
Hydrocephalus surveillance following CSF diversion: a modified Delphi study
David S Hersh, Jonathan E Martin, Ruth E Bristol, et al.
The Journal of Experimental Medicine
|
December 6, 2017
Novel and shared neoantigen derived from histone 3 variant H3.3K27M mutation for glioma T cell therapy
Zinal S Chheda, Gary Kohanbash, Kaori Okada, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 18, 2018
Extensive Molecular and Clinical Heterogeneity in Patients With Histologically Diagnosed CNS-PNET Treated as a Single Entity: A Report From the Children's Oncology Group Randomized ACNS0332 Trial
Eugene I Hwang, Marcel Kool, Peter C Burger, et al.
Brain Pathology (Zurich, Switzerland)
|
March 5, 2013
Histological predictors of outcome in ependymoma are dependent on anatomic site within the central nervous system
Aditya Raghunathan, Khalida Wani, Terri S Armstrong, et al.
Neuro-Oncology Advances
|
April 10, 2024
Vorinostat, temozolomide or bevacizumab with irradiation and maintenance BEV/TMZ in pediatric high-grade glioma: A Children's Oncology Group Study
Rishi R Lulla, Allen Buxton, Mark D Krailo, et al.
Page
of 31